In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

What will impact your daily practice and how?

Major ESC Clinical Practice Guidelines will be presented during ESC Congress in Barcelona (26-30 Aug. 2017)
Discover the many sessions and face-to-face exchanges.

More

Practice Guideline Track on Cardiovascular Disease Prevention

Guidelines into Practice

Primary care
Prevention
Dyslipidaemias


Contributors:  Special thanks to Professor Ugo Corrà

Based on the 2016 ESC Guidelines on CVD Prevention in Clinical Practice

Webinars on this topic

 2016 ESC webinar on "New ESC CVD prevention guidelines 2016: how should they change my clinical practice in preventive cardiology?"  streamed live on 21 Feb 2017: Watch the recording.

Part 1 - Overview of the Guidelines

Session title Slides Webcast
2016 European Guidelines on cardiovascular disease prevention in clinical practice. Cardiovascular risk assessment for a busy clinician    
2016 European Guidelines on cardiovascular disease prevention in clinical practice. Do we need an ECG before starting physical activity?    

Part 2 - Topics in focus

Topic/Section Session title Slides Webcast
A naturally randomised trial comparing the effect of long-term exposure to lower LDL-C, lower SBP, or both on the risk of cardiovascular disease. Meet the Trialist III    
Are clinicians following statin intensity recommendations? Insights in 135 U.S community practices in the PALM registry Breaking down barriers in secondary prevention    
Management of overweight and obesity in patients at high cardiovascular risk across Europe: Results from EUROASPIRE IV survey Breaking down barriers in secondary prevention    
Barriers to uptake of cardio-protective treatment in a community elderly population of stage B heart failure Breaking down barriers in secondary prevention    
What the Guidelines tell us. Behavioural change in the non-compliant high-risk patient Primary prevention    
Can exercise make the difference? Benefits of exercise training After CRT    
can technology help? Can mobile apps help prevent cardiovascular disease across the life span? Engaging patients to self-manage    
Can technology help? What works in smoking cessation in heart disease?    
Children’s modern lifestyle – Between fit and fat. Cardiovascular risk factors in children and youth: a call for action    
Evidence-based management of psychosocial risk factors Should we consider psychosocial determinants of cardiovascular disease?    
Gaps in knowledge and implementation strategies: what do we know? Secondary prevention after myocardial infarction: how can we go further?    
How to bring sex into the consultation? Let's talk about sex! Important for patients - Difficult for professionals    
Importance of health systems and public health to overcome barriers in regional CVD prevention How should the global cardiology community respond to the preventable global epidemic of CVD?    
Multiple facets of collaboration: a European assessment of cardiologists needs in relation to education, guidelines, research and roles of their specialty society The future is in education